Durvalumab Gets FDA Green Light for Treatment of Extensive-Stage SCLC May, Brandon May, Brandon Less Oncology Times. 42(12):38, June 20, 2020. Favorites PDF Get Content & Permissions Free
Clinical Activity of RAF/MEK + FAK Combo in KRAS-Mutant Tumors Nalley, Catlin Nalley, Catlin Less Oncology Times. 42(12):32,37, June 20, 2020. Favorites PDF Get Content & Permissions Free
Incidence of Tobacco & Vaping in Low-Income, Ethnically Dense Communities Froelich, Warren Froelich, Warren Less Oncology Times. 42(11):32, June 5, 2020. Favorites PDF Get Content & Permissions Free
Leukemia Drugs Hold Promise for Treatment-Resistant Lung Cancer Less Oncology Times. 42(6):27, March 20, 2020. Favorites PDF Get Content & Permissions Free
Genomic Analyses Predict Response to Immunotherapy in Lung Cancer Less Oncology Times. 42(6):20, March 20, 2020. Favorites PDF Get Content & Permissions Free
Reducing Malnutrition Among Patients With Lung Cancer Barry Thias, Bridget Barry Thias, Bridget Less Oncology Times. 42(5):27, March 5, 2020. Favorites PDF Get Content & Permissions Free
Global Green Light for CT Lung Cancer Screening Goodwin, Peter M. Goodwin, Peter M. Less Oncology Times. 42(5):20-21, March 5, 2020. Favorites PDF Get Content & Permissions Free
Surgeon General Urges Clinicians to Do More to Curb Smoking Eastman, Peggy Eastman, Peggy Less Oncology Times. 42(4):1,6, February 20, 2020. Favorites PDF Get Content & Permissions Free
Nivolumab + Ipilimumab in Patients with Advanced NSCLC Less Oncology Times. 42(2):28, January 20, 2020. Favorites PDF Get Content & Permissions Free
Pembrolizumab as First-Line Treatment in Non-Squamous NSCLC Less Oncology Times. 42(2):27,30, January 20, 2020. Favorites PDF Get Content & Permissions Free
Linking Immune Cell to Failure of Checkpoint Inhibitors in Lung Cancer Less Oncology Times. 42(2):20, January 20, 2020. Favorites PDF Get Content & Permissions Free
‘It's a Big Deal’: Surgeon Group Studying Thoracic Disease Is Growing Conick, Hal Conick, Hal Less Oncology Times. 42(1):22, January 5, 2020. Favorites PDF Get Content & Permissions Free
SBRT Heightens Immune Response in Some Metastatic NSCLC Patients Samson, Kurt Samson, Kurt Less Oncology Times. 41(23):36, December 5, 2019. Favorites PDF Get Content & Permissions Free
CASPIAN Trial Highlights Extensive Stage Small Cell Lung Cancer Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 41(22):38, November 20, 2019. Favorites PDF Get Content & Permissions Free
Pembrolizumab Plus Chemo for Advanced Non-Small Cell Lung Cancer Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 41(22):37, November 20, 2019. Favorites PDF Get Content & Permissions Free
Vaping: Regulation Is Required to Deter Potential Oncological Outcomes Nolen, Lindsey Nolen, Lindsey Less Oncology Times. 41(22):11-14, November 20, 2019. Favorites PDF Get Content & Permissions Free
Trial of Irreversible KRASG12C Inhibitor AMG 510 Reveals Clinical Activity Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 41(21):33, November 5, 2019. Favorites PDF Get Content & Permissions Free
The Benefit of Using Immunotherapy With Ablation in NSCLC May, Brandon May, Brandon Less Oncology Times. 41(19):15, October 5, 2019. Favorites PDF Get Content & Permissions Free
Advances in Next-Generation Sequencing for Non-Small Cell Lung Cancer Vidaurri, Vincent Vidaurri, Vincent Less Oncology Times. 41(17):19,27, September 5, 2019. Favorites PDF Get Content & Permissions Free
Pembrolizumab Provides Long-Term Survival in Advanced Lung Cancer Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 41(16):33, August 20, 2019. Favorites PDF Get Content & Permissions Free
Traditional & Complementary Treatments for Mesothelioma Patients Less Oncology Times. 41(16):24, August 20, 2019. Favorites PDF Get Content & Permissions Free
Lung Cancer Responses With RET-Fusion Targeted Therapy Goodwin, Peter M. Goodwin, Peter M. Less Oncology Times. 41(15):34, August 5, 2019. Favorites PDF Get Content & Permissions Free
Advanced NSCLC: EGFR Exon 20 Targeting Success Goodwin, Peter M. Goodwin, Peter M. Less Oncology Times. 41(15):29, August 5, 2019. Favorites PDF Get Content & Permissions Free
New Digital Tools Could Improve Treatment for Lung Cancer Patients Hirsch, Fred R. Hirsch, Fred R. Less Oncology Times. 41(13):26,29, July 5, 2019. Favorites PDF Get Content & Permissions Free
Predictive Models Could Individualize Therapy for Small Cell Lung Cancer Goodwin, Peter M. Goodwin, Peter M. Less Oncology Times. 41(11):30, June 5, 2019. Favorites PDF Get Content & Permissions Free
Gene Profiling in Recurrent Small Cell Lung Cancer Hepp, Rebecca Hepp, Rebecca Less Oncology Times. 41(11):28-29, June 5, 2019. Favorites PDF Get Content & Permissions Free
Ways to Improve Care Access for Underserved Lung Cancer Patients May, Brandon May, Brandon Less Oncology Times. 41(11):15, June 5, 2019. Favorites PDF Get Content & Permissions Free
MET Plus EGFR Inhibitors in Resistant Lung Cancer Patients Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 41(10):35, May 20, 2019. Favorites PDF Get Content & Permissions Free
Pembrolizumab Shows Promising Activity in Small Cell Lung Cancer Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 41(10):32, May 20, 2019. Favorites PDF Get Content & Permissions Free
Novel Approach Shows Promise for Treatment of SCLC Brophy Marcus, Mary Brophy Marcus, Mary Less Oncology Times. 41(10):24, May 20, 2019. Favorites PDF Get Content & Permissions Free
Liquid Biopsy Identifies Lung Cancer Biomarkers Faster Than Tissue Tests Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 41(8):33, April 20, 2019. Favorites PDF Get Content & Permissions Free
Higher Doses of Second-Line Nivolumab Safe & Effective for Advanced NSCLC Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 41(8):30, April 20, 2019. Favorites PDF Get Content & Permissions Free
Prophylactic Cranial Irradiation Use Down Sharply for Extensive-Stage SCLC Samson, Kurt Samson, Kurt Less Oncology Times. 41(8):27, April 20, 2019. Favorites PDF Get Content & Permissions Free
Web-Based Guideline Tool Increases NSCLC Patients in Decisions Samson, Kurt Samson, Kurt Less Oncology Times. 41(8):26, April 20, 2019. Favorites PDF Get Content & Permissions Free
Oligometastatic NSCLC: Consolidation Therapy May Provide Survival Edge Samson, Kurt Samson, Kurt Less Oncology Times. 41(8):25,37, April 20, 2019. Favorites PDF Get Content & Permissions Free
ZEB1 Throttles Therapeutic Target, Protects KRAS-Mutant Lung Cancer Less Oncology Times. 41(7):32-34, April 5, 2019. Favorites PDF Get Content & Permissions Free
Immunotherapy Advances in Non-Small Cell Lung Cancer Johnson, Melissa; Zimmerman, Lisa J. Johnson, Melissa; Zimmerman, Lisa J. Less Oncology Times. 41(7):12,13,35, April 5, 2019. Favorites PDF Get Content & Permissions Free
Lorlatinib (Lorbrena®) Mann, Janelle E. Mann, Janelle E. Less Oncology Times. 41(6):5, March 20, 2019. Favorites PDF Get Content & Permissions Free
Complications of Diagnostic Tests Following Lung Cancer Screening Brophy Marcus, Mary Brophy Marcus, Mary Less Oncology Times. 41(6):21-22, March 20, 2019. Favorites PDF Get Content & Permissions Free
Navigating a New Path to Test Peripheral Lung Nodules Holt, Chuck Holt, Chuck Less Oncology Times. 41(6):1-2, March 20, 2019. Favorites PDF Get Content & Permissions Free
Free Lung Cancer Screening Builds Valuable Relationships With Patients Less Oncology Times. 41(4):34, February 20, 2019. Favorites PDF Get Content & Permissions Free
Complication Rates & Costs of Lung Cancer Diagnostic Tests Less Oncology Times. 41(3):28, February 5, 2019. Favorites PDF Get Content & Permissions Free
OAK Trial Shows Fast Progression Is Not More Common With Atezolizumab Less Oncology Times. 41(2):36, January 20, 2019. Favorites PDF Get Content & Permissions Free
Second-Line Nivolumab Is Not Superior to Chemotherapy in SCLC Less Oncology Times. 41(2):21, January 20, 2019. Favorites PDF Get Content & Permissions Free
First-Line Immunotherapy Combination Fails to Improve OS in Lung Cancer Less Oncology Times. 41(2):20, January 20, 2019. Favorites PDF Get Content & Permissions Free
Long Overall Survival in Ceritinib-Treated ALK-Positive Lung Cancer Goodwin, Peter M. Goodwin, Peter M. Less Oncology Times. 40(22):34, November 20, 2018. Favorites PDF Get Content & Permissions Free
Detection of Early-Stage Lung Cancer When Surgical Cure Still Possible Less Oncology Times. 40(21):26, November 5, 2018. Favorites PDF Get Content & Permissions Free
Treatment Resistance in EGFR-Mutant NSCLC & Acquired RET Fusion Less Oncology Times. 40(20):50, October 20, 2018. Favorites PDF Get Content & Permissions Free
Promising Results for Entrectinib Against ROS1-Positive NSCLC Less Oncology Times. 40(20):45, October 20, 2018. Favorites PDF Get Content & Permissions Free
Brigatinib Becomes Potential First-Line Option for ALK-Positive NSCLC Less Oncology Times. 40(20):44, October 20, 2018. Favorites PDF Get Content & Permissions Free
LOXO-292 Durability Update in Patients With RET Fusion-Positive NSCLC Less Oncology Times. 40(20):43, October 20, 2018. Favorites PDF Get Content & Permissions Free
Poziotinib Sustains High Response Rates Against Lung Cancer Mutation Less Oncology Times. 40(19):22, October 5, 2018. Favorites PDF Get Content & Permissions Free
Promising Immunotherapies in Early-Stage Lung Cancer Less Oncology Times. 40(16):16, August 20, 2018. Favorites PDF Get Content & Permissions Free
Biomarker Panel Boosts Lung Cancer Risk Assessment for Smokers Less Oncology Times. 40(16):28, August 20, 2018. Favorites PDF Get Content & Permissions Free
Potential Value of Real-World Evidence in Lung Cancer Care Eastman, Peggy Eastman, Peggy Less Oncology Times. 40(16):1,7,13, August 20, 2018. Favorites PDF Get Content & Permissions Free
Genome-Wide Sequencing Detects Early Stage Lung Cancer From Blood Samples Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 40(14):31, July 20, 2018. Favorites PDF Get Content & Permissions Free
Adding Immunotherapy to Chemotherapy in Advanced Squamous Lung Cancer Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 40(14):29, July 20, 2018. Favorites PDF Get Content & Permissions Free
Pembrolizumab Monotherapy Extended Survival in Advanced Lung Cancer Goodwin, Peter M. Goodwin, Peter M. Less Oncology Times. 40(13):36,55, July 5, 2018. Favorites PDF Get Content & Permissions Free
Upfront Genetic Testing of Non-Small Cell Lung Cancer Is Cost-Effective Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 40(13):34, July 5, 2018. Favorites PDF Get Content & Permissions Free
Registry Reveals Low Lung Cancer Screening of Smokers Fuerst, Mark L. Fuerst, Mark L. Less Oncology Times. 40(13):33, July 5, 2018. Favorites PDF Get Content & Permissions Free
Lung Cancer: Geriatric Assessment Before Concurrent Chemo-Radiotherapy Goodwin, Peter M. Goodwin, Peter M. Less Oncology Times. 40(12):39, June 20, 2018. Favorites PDF Get Content & Permissions Free
Handgrip Strength Predicts Survival in Elderly Patients With Lung Cancer Goodwin, Peter M. Goodwin, Peter M. Less Oncology Times. 40(12):34, June 20, 2018. Favorites PDF Get Content & Permissions Free
Neoadjuvant Nivolumab in Patients With Resectable Non-Small Cell Lung Cancer Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 40(11):41-42, June 5, 2018. Favorites PDF Get Content & Permissions Free
Evaluating Nivolumab + Ipilimumab vs. Standard Chemo in NSCLC Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 40(11):38,40, June 5, 2018. Favorites PDF Get Content & Permissions Free
Treatment for ALK-Positive & ALK-Negative Inflammatory Myofibroblastic Tumors Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 40(11):35-36, June 5, 2018. Favorites PDF Get Content & Permissions Free
Evaluating Chemotherapy & Pembrolizumab in Metastatic NSCLC Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 40(11):33-34, June 5, 2018. Favorites PDF Get Content & Permissions Free
Longer Symptom Improvement in ALK-Positive Lung Cancer Less Oncology Times. 40(11):31, June 5, 2018. Favorites PDF Get Content & Permissions Free
Immunotherapy & Long-Term Survival for Lung Cancer Patients Less Oncology Times. 40(11):24, June 5, 2018. Favorites PDF Get Content & Permissions Free
Immunotherapy Shows Promise Among Lung Cancer Patients Nalley, Catlin Nalley, Catlin Less Oncology Times. 40(10):40-41, May 20, 2018. Favorites PDF Get Content & Permissions Free
New Immunotherapy for Lung Cancer Shows Promise of Success Less Oncology Times. 40(9):30, May 5, 2018. Favorites PDF Get Content & Permissions Free
Updated ASTRO Guideline for Palliative Lung Radiation Less Oncology Times. 40(9):27, May 5, 2018. Favorites PDF Get Content & Permissions Free
Crizotinib (Xalkori®) Skirvin, J. Andrew Skirvin, J. Andrew Less Oncology Times. 39(24):30, December 25, 2017. Favorites PDF Get Content & Permissions Free
Osimertinib Improves PFS in Asian EGFR-Mutated Lung Cancer Patients Less Oncology Times. 39(24):51, December 25, 2017. Favorites PDF Get Content & Permissions Free
Mutations in Cerebrospinal Fluid in Lung Cancer With Brain Metastases Less Oncology Times. 39(24):45, December 25, 2017. Favorites PDF Get Content & Permissions Free
Genetic Testing for EGFR Mutations in NSCLC Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 39(24):20,33, December 25, 2017. Favorites PDF Get Content & Permissions Free
Chronic Stress Hormones May Promote Resistance to EGFR Inhibitors Less Oncology Times. 39(23):64, December 10, 2017. Favorites PDF Get Content & Permissions Free
Positive Findings for Nintedanib in Malignant Pleural Mesothelioma Bennett, Christina Bennett, Christina Less Oncology Times. 39(23):27, December 10, 2017. Favorites PDF Get Content & Permissions Free
Maintenance Therapy in Advanced Small Cell Lung Cancer Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 39(23):1,6,10, December 10, 2017. Favorites PDF Get Content & Permissions Free Take the CME Test
Lung Cancer Driver ALK-Fusion Found in Melanoma Less Oncology Times. 39(22):58, November 25, 2017. Favorites PDF Get Content & Permissions Free
The Use of Liquid Biopsies in Patients With NSCLC Bhadra, Krish; Garwood, Susan; Sharma, Nitika; More Bhadra, Krish; Garwood, Susan; Sharma, Nitika; Walker, Paul Less Oncology Times. 39(22):20-21, November 25, 2017. Favorites PDF Get Content & Permissions Free
Stage III NSCLC Survival Rate Doubles With Standard Radiation Therapy Samson, Kurt Samson, Kurt Less Oncology Times. 39(21):58, November 10, 2017. Favorites PDF Get Content & Permissions Free
Blood Test for Tumor Cell DNA May Help Predict Localized NSCLC Samson, Kurt Samson, Kurt Less Oncology Times. 39(21):57, November 10, 2017. Favorites PDF Get Content & Permissions Free
Nab-Paclitaxel Monotherapy Shows Promise for Previously Treated, Advanced NSCLC Nalley, Catlin Nalley, Catlin Less Oncology Times. 39(21):47, November 10, 2017. Favorites PDF Get Content & Permissions Free
ALUR Study Results Comparing ALK Inhibitor Alectinib vs. Chemotherapy Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 39(21):46-47, November 10, 2017. Favorites PDF Get Content & Permissions Free
Researchers Describe Rare Phenomenon in Lung Cancer Bennett, Christina Bennett, Christina Less Oncology Times. 39(21):44, November 10, 2017. Favorites PDF Get Content & Permissions Free
Anti-Inflammatory Therapy Cuts Risk of Lung Cancer Less Oncology Times. 39(18):30, September 25, 2017. Favorites PDF Get Content & Permissions Free
First-Line Nivolumab in Stage IV or Recurrent Non-Small Cell Lung Cancer Carbone, David P. Carbone, David P. Less Oncology Times. 39(17):28-29, September 10, 2017. Favorites PDF Get Content & Permissions Free
Evaluating First-Line Ceritinib Therapy in ALK-Rearranged NSCLC Patients Simoneux, Richard Simoneux, Richard Less Oncology Times. 39(17):23,24,32, September 10, 2017. Favorites PDF Get Content & Permissions Free
Evading Therapeutic Resistance Through Collateral Sensitivity: A Paradigm Shift? Scott, Jacob; Dhawan, Andrew Scott, Jacob; Dhawan, Andrew Less Oncology Times. 39(15):22, August 10, 2017. Favorites PDF Get Content & Permissions Free
ASTRO Issues Guideline for Use of SBRT in Early-Stage Lung Cancer Less Oncology Times. 39(13):25,28-29, July 10, 2017. Favorites PDF Get Content & Permissions Free
Brigatinib Granted Accelerated Approval for NSCLC Less Oncology Times. 39(11):39, June 10, 2017. Favorites PDF Get Content & Permissions Free
Lung Cancer May Go Undiagnosed in Metastatic Kidney Cancer Patients Bowman, I. Alex Bowman, I. Alex Less Oncology Times. 39(11):1,11, June 10, 2017. Favorites PDF Get Content & Permissions Free
Osimertinib Granted Full Approval for NSCLC Less Oncology Times. 39(9):34, May 10, 2017. Favorites PDF Get Content & Permissions Free
Mutations in Treatment-Resistant NSCLC Can Change Over Time Samson, Kurt Samson, Kurt Less Oncology Times. 39(8):47, April 25, 2017. Favorites PDF Get Content & Permissions Free
‘Modest’ Toxicity With Checkpoint Inhibitors Plus Radiotherapy for NSCLC Samson, Kurt Samson, Kurt Less Oncology Times. 39(8):45, April 25, 2017. Favorites PDF Get Content & Permissions Free
NSCLC Treatment Utilization, Survival Rates Hindered By Racial Disparities Samson, Kurt Samson, Kurt Less Oncology Times. 39(8):37, April 25, 2017. Favorites PDF Get Content & Permissions Free
SBRT Found Safe, Effective in Elderly With Inoperable Early-Stage NSCLC Samson, Kurt Samson, Kurt Less Oncology Times. 39(8):36, April 25, 2017. Favorites PDF Get Content & Permissions Free
Study Results Support Use of Proton Therapy for Recurrent NSCLC Samson, Kurt Samson, Kurt Less Oncology Times. 39(8):34,51, April 25, 2017. Favorites PDF Get Content & Permissions Free
The Latest Clinical Trials Involving Targeted Therapies for NSCLC Simoneaux, Richard Simoneaux, Richard Less Oncology Times. 39(7):1,12-14, April 10, 2017. Favorites PDF Get Content & Permissions Free Take the CME Test
Chemotherapy Effectiveness & Initiation Time After Lung Cancer Surgery Less Oncology Times. 39(3):30, February 10, 2017. Favorites PDF Get Content & Permissions Free
